Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Domanski

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
European Heart Journal|February 2, 2006
Prognosis in atrial fibrillationMichael Domanski
Journal of the American College of Cardiology|April 20, 2004
The metabolic syndromeMichael Domanski, Michael Proschan
Current Treatment Options in Cardiovascular Medicine|May 26, 2005
Heart Failure with Preserved Systolic FunctionMichael Domanski, Eliot Peyster
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|August 16, 2006
Catheter ablation of atrial fibrillation: a treatment frontierMichael Domanski, Albert L Waldo
Journal of Cardiac Failure|February 18, 2004
Prevalence and predictors of heart failure with preserved systolic function: community hospital admissions of a racially and gender diverse elderly populationEliot Peyster, James Norman, Michael Domanski
The New England Journal of Medicine|April 12, 2013
Revascularization strategies in patients with diabetesMichael E Farkouh, Michael Domanski, Valentin Fuster
Journal of Cardiac Failure|June 10, 2006
Diuretic use, progressive heart failure, and death in patients in the DIG studyMichael Domanski, Xin Tian, Mark Haigney, et al.
Nature Reviews. Cardiology|November 3, 2011
Can we dramatically reduce the incidence of coronary heart disease?Michael Domanski, Donald Lloyd-Jones, Valentin Fuster, et al.
The American Journal of Cardiology|May 12, 2007
Effect of statin therapy on survival in patients with nonischemic dilated cardiomyopathy (from the Beta-blocker Evaluation of Survival Trial [BEST])Michael Domanski, Sean Coady, Jerome Fleg, et al.
The Medical Clinics of North America|March 7, 2012
Atherosclerosis in chronic kidney disease: lessons learned from glycation in diabetesDilbahar S Mohar, Ailin Barseghian, Nezam Haider, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
European Heart Journal|February 2, 2006
Prognosis in atrial fibrillationMichael Domanski
Journal of the American College of Cardiology|April 20, 2004
The metabolic syndromeMichael Domanski, Michael Proschan
Current Treatment Options in Cardiovascular Medicine|May 26, 2005
Heart Failure with Preserved Systolic FunctionMichael Domanski, Eliot Peyster
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|August 16, 2006
Catheter ablation of atrial fibrillation: a treatment frontierMichael Domanski, Albert L Waldo
Journal of Cardiac Failure|February 18, 2004
Prevalence and predictors of heart failure with preserved systolic function: community hospital admissions of a racially and gender diverse elderly populationEliot Peyster, James Norman, Michael Domanski
The New England Journal of Medicine|April 12, 2013
Revascularization strategies in patients with diabetesMichael E Farkouh, Michael Domanski, Valentin Fuster
Journal of Cardiac Failure|June 10, 2006
Diuretic use, progressive heart failure, and death in patients in the DIG studyMichael Domanski, Xin Tian, Mark Haigney, et al.
Nature Reviews. Cardiology|November 3, 2011
Can we dramatically reduce the incidence of coronary heart disease?Michael Domanski, Donald Lloyd-Jones, Valentin Fuster, et al.
The American Journal of Cardiology|May 12, 2007
Effect of statin therapy on survival in patients with nonischemic dilated cardiomyopathy (from the Beta-blocker Evaluation of Survival Trial [BEST])Michael Domanski, Sean Coady, Jerome Fleg, et al.
The Medical Clinics of North America|March 7, 2012
Atherosclerosis in chronic kidney disease: lessons learned from glycation in diabetesDilbahar S Mohar, Ailin Barseghian, Nezam Haider, et al.
Pageof 5